| Gender (Male/Female) | 501/588 (46/54%) |
| Age, yrs (mean) | 64 (28 - 102) |
| IAV (mean, mil) | 2.9 (sd 0.16 mL, 2.5 - 3.0 mL) |
| HOS | 91.1% |
| ISB G0 | 5 (0.46%) |
| ISB G1 | 75 (6.9%) |
| ISBG2 | 678 (62.2%) |
| ISBG3 | 331 (30.4%) |
| IMB G0 | 42 (3.8%) |
| IMB G1 | 468 (42.9%) |
| IMB G2 | 520 (47.8%) |
| IMB G3 | 59 (5.4%) |
| CA | 522 (47.9%) |
| FAV (mean, mL) | 4.29 (sd 2.17mL, 2.5 - 15 mL) |
| SSa (yes/no) | 371 (34.1%) |
| SSs (yes/no) | 32 (2.9%) |
| (non-HOS) ISB G0 | 5 (5.1%) |
| (non-HOS) ISB G1 | 56 (57.1%) |
| (non-HOS) ISB G2 | 36 (36.7%) |
| (non-HOS) ISB G3 | 1 (1.0%) |
| (non-HOS) IMB G0 | 42 (42.8%) |
| (non-HOS) IMB G1 | 55 (56.1%) |
| (non-HOS) IMB G2 | 0 (0%) |
| (non-HOS) IMB G3 | 1 (1.0%) |
| (non-HOS) CA | 97 (98.9%) |
| (non-HOS) FAV (mean, mL) | 9.9 (sd 1.99 mL, 3.0 - 15 mL) |
| (HOS-only) ISB G0 | 0 (0%) |
| (HOS-only) ISB G1 | 19 (1.9%) |
| (HOS-only) ISB G2 | 642 (64.8%) |
| (HOS-only) ISB G3 | 330 (33.3%) |
| (HOS-only) IMB G0 | 0 (0%) |
| (HOS-only) IMB G1 | 413 (41.6%) |
| (HOS-only) IMB G2 | 520 (52.4%) |
| (HOS-only) IMB G3 | 58 (5.8%) |
| (HOS-only) CA | 413 (41.6%) |
| (HOS-only) FAV (mean/mL) | 3.7 mL (sd 1.16 mL, 2.5 - 9 mL) |